Search

Search Results
Results 7021 - 7030 of 7072 for parkinson
  • Abyraz
    Drug - 19 Jul 2022
    Consumer Medicine Information (CMI) about Abyraz intended for persons living in Australia.
  • Phenergan
    Drug - 14 Jun 2022
    Consumer Medicine Information (CMI) about Phenergan intended for persons living in Australia.
  • Tinasil
    Drug - 3 Jun 2022
    Consumer Medicine Information (CMI) about Tinasil (Terbinafine) intended for persons living in Australia.
  • DBL Papaverine Hydrochloride
    Drug - 23 Mar 2022
    Consumer Medicine Information (CMI) about DBL Papaverine Hydrochloride intended for persons living in Australia.
  • Bisolvon Dry Oral Liquid
    Drug - 11 Mar 2022
    Consumer Medicine Information (CMI) about Bisolvon Dry Oral Liquid intended for persons living in Australia.
  • Clopine
    Drug - 2 Mar 2022
    Consumer Medicine Information (CMI) about Clopine (clozapine) intended for persons living in Australia.
  • Physiotens
    Drug - 17 Feb 2022
    Consumer Medicine Information (CMI) about Physiotens intended for persons living in Australia.
  • Moxonidine Viatris
    Drug - 17 Feb 2022
    Consumer Medicine Information (CMI) about Moxonidine Viatris intended for persons living in Australia.
  • Moxonidine GX
    Drug - 17 Feb 2022
    Consumer Medicine Information (CMI) about Moxonidine GX intended for persons living in Australia.
  • Teveten Plus
    Drug - 16 Feb 2022
    Consumer Medicine Information (CMI) about Teveten Plus intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback